Biostate AI, using AI and RNA sequencing for precision medicine, raised $12 million in Series A funding. The funding will accelerate its platform's expansion, cutting RNA sequencing costs and improving data quality. The platform is used in over 150 pilot projects, processing 10,000+ samples. Biostate aims to create an end-to-end platform for diagnostics and therapeutics.
